STEMLINE THERAPEUTICS
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology compounds directed to cancer stem cell targets. Stemline’s lead compound, SL-401, targets the interleukin-3 receptor present on multiple hematological cancers including leukemia blasts and leukemia cancer stem cells. SL-401 has demonstrated single agent anti-tumor activity at tolerable doses in a multi-center Phase I human trial. Behind its lead, Stemline is developing a ... broad portfolio of compounds directed at this and other high value cancer stem cell targets of a variety of hematological and solid cancers. In addition, Stemline has built a robust discovery platform called “StemScreen®†which the Company has utilized to identify multiple compounds that target and impair cancer stem cells. Stemline also possesses a comprehensive intellectual property portfolio that includes the earliest filings in the cancer stem cell field covering cancer stem cell-directed therapeutics, diagnostics, and drug screening.
STEMLINE THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Oncology
Founded:
2003-08-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.stemline.com
Total Employee:
11+
Status:
Active
Contact:
646-502-2311
Total Funding:
195.09 M USD
Technology used in webpage:
Domain Not Resolving SPF Amazon HSTS IPv6 Google Apps For Business Microsoft Azure DNS Common Name Invalid GoDaddy DNS AWS Global Accelerator
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Avrobio
Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Biohaven Pharmaceutical
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Cleveland Diagnostics
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Karyopharm Therapeutics
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Kenneth Hoberman Chief Operating Officer @ Stemline Therapeutics
Chief Operating Officer
Ivan Bergstein Chief Executive Officer and Founder @ Stemline Therapeutics
Chief Executive Officer and Founder
Founder
Stock Details
Investors List
Pequot Capital
Pequot Capital investment in Series A - Stemline Therapeutics
Official Site Inspections
http://www.stemline.com Semrush global rank: 3.29 M Semrush visits lastest month: 4.29 K
- Host name: cloudproxy10040.sucuri.net
- IP address: 192.124.249.40
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Stemline Therapeutics"
Management - Stemline Therapeutics
Mr. Gionco is the Senior Vice President, Financial and Chief Accounting Officer at Stemline Therapeutics. Mr. Gionco was previously Vice President, Chief Financial Officer, and Chief Accounting Officer at Savient Pharmaceuticals, Inc., where …See details»
About Us - Stemline Therapeutics
Stemline Therapeutics, a part of the Menarini Group, is focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to …See details»
Stemline Therapeutics US Medical
Welcome to Stemline Therapeutics US Medical. This site is intended for healthcare professionals licensed in the United States and is for nonpromotional informational purposes only. Please verify that you are a licensed healthcare …See details»
Stemline Therapeutics - Crunchbase Company Profile …
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology compounds directed to cancer stem cell targets. Stemline’s lead compound, SL-401, targets the interleukin-3 …See details»
Menarini Group to Acquire Stemline Therapeutics in …
Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its …See details»
Menarini Group Completes Acquisition of Stemline …
Jun 10, 2020 Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its …See details»
Dr. Ivan Bergstein, M.D. - Regenerative Medicine Now
Dr. Bergstein is Chief Executive Officer and Founder of Stemline Therapeutics. He led Stemline through multiple private financings and ultimately its successful IPO and subsequent follow-on …See details»
Company Overview - Stemline Therapeutics
Stemline Therapeutics is a society of the Menarini Group. Privacy Preference Center. Privacy PreferencesSee details»
Stemline Therapeutics, Inc., a Menarini Group Company
Stemline is committed to applying our scientific leadership to transform the lives of people with cancer. Stemline Therapeutics is continuing to invest in research and conduct clinical trials to …See details»
Stemline Therapeutics - Contacts, Employees, Board Members
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells. Search Crunchbase Start Free TrialSee details»
Menarini Group to Acquire Stemline Therapeutics in Transaction …
FLORENCE and NEW YORK – May 4, 2020 – Menarini Group, a privately held Italian pharmaceutical and diagnostics company, and Stemline Therapeutics Inc., a commercial …See details»
Stemline Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Nov 1, 2024 FLORENCE, Italy & NEW YORK--(BUSINESS WIRE)-- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline …See details»
Menarini Group Completes Acquisition of Stemline Therapeutics
FLORENCE – June 10, 2020 – Menarini Group, a privately held Italian pharmaceutical and diagnostics company, today announced that is has successfully completed the acquisition of …See details»
Stemline ARC® | Home Page
Stemline ARC ® provides access support, reimbursement assistance, and educational resources to help patients and the healthcare professionals involved in their care so patients can focus …See details»
Contact Us - Stemline Therapeutics
Stemline Therapeutics, Inc. 750 Lexington Avenue, 4th Floor New York, NY 10022 646-502-2310See details»
Stemline, a Menarini Group Company - 2025 ASCO® Annual …
Stemline Therapeutics, a part of the Menarini Group, is focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of …See details»
Ivan Bergstein - Chief Executive Officer and Founder @ Stemline ...
Dr. Bergstein is Chief Executive Officer and Founder of Stemline Therapeutics. He led Stemline through multiple rounds of private financing and ultimately its successful IPO and subsequent …See details»
Menarini Group to Acquire Stemline Therapeutics in Transaction …
Nov 22, 2018 Menarini Group and Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel …See details»
Menarini Makes Big US Oncology Move with Stemline Acquisition
Jun 18, 2020 The acquisition of Stemline, a commercial-stage firm working on the development and commercialisation of novel oncology therapeutics, will establish a footprint for Menarini in …See details»
Hamilton non-profit creates spaces for Black girls in STEM and …
45 minutes ago Awards, presented by the non-profit organization Sisters in Sync. Held on International Day of the Girl, Oct. 11, the gala event celebrated Black girls aged six to 21 from …See details»